ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

10 links0 made here, not in the record19 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07578116Adding Surgery andRadiation to the UsualTreatment for HER2-PositiveBreast Cancer That HadAlready Spread at DiagnosisSWOG Cancer Research NetworkPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Version of 2026-10-13CONDITIONSBreast NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSINT011626Entry “Cyclin-Dependent Kinase 4 Inhi…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT011627Entry “Cyclin-Dependent Kinase 6 Inhi…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundINT011532Entry “HER2-targeted Therapy”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010015Entry “Hormone Therapy”, read by our …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundPertuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · BackgroundBackground · establishedTaxaneEntry “Taxane Compound”, read by our …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumab deruxtecanIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · BackgroundBackground · establishedAdo-Trastuzumab EmtansineEntry “Trastuzumab Emtansine”, read b…›Nov 2 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · option

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT011626

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Cyclin-Dependent Kinase 4 Inhibitor”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Nov 2INT011626Claude Opus 5.5BackgroundCurrent
Nov 2INT011627Claude Opus 5.5BackgroundCurrent
Nov 2INT011532Claude Opus 5.5TestedCurrent
Nov 2INT010015Claude Opus 5.5BackgroundCurrent
Nov 2PertuzumabClaude Opus 5.5Background · establishedCurrent
Nov 2TaxaneClaude Opus 5.5BackgroundCurrent
Nov 2TrastuzumabClaude Opus 5.5TestedCurrent
Nov 2Trastuzumab deruxtecanClaude Opus 5.5Background · establishedCurrent
Nov 2Ado-Trastuzumab EmtansineClaude Opus 5.5Background · optionCurrent
Nov 18INT011626Rule based · role ruleBackgroundAgrees
Nov 18INT011627Rule based · role ruleBackgroundAgrees
Nov 18INT011532Rule based · role ruleTestedAgrees
Nov 18INT010015Rule based · role ruleBackgroundAgrees
Nov 18PertuzumabRule based · role ruleBackgroundAgrees
Nov 18TaxaneRule based · role ruleBackgroundAgrees
Nov 18TrastuzumabRule based · role ruleTestedAgrees
Nov 18Trastuzumab deruxtecanRule based · role ruleBackgroundAgrees
Nov 18Ado-Trastuzumab EmtansineRule based · role ruleBackgroundAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.